Literature DB >> 20229286

Optimisation of the purification process of a tumour-targeting antibody produced in N. benthamiana using vacuum-agroinfiltration.

Raffaele Lombardi1, Maria Elena Villani, Mariasole Di Carli, Patrizia Brunetti, Eugenio Benvenuto, Marcello Donini.   

Abstract

It was previously demonstrated that the tumour-targeting antibody mAb H10 can be transiently expressed and purified at high levels in Nicotiana benthamiana by using a vacuum-agroinfiltration system boosted by the use of a virus silencing suppressor protein. Scope of this work was to analyse different steps of protein extraction from agroinfiltrated leaves to optimise the purification process of the secretory mAb H10 providing new insights in the field of large-scale plant production. Two different extraction procedures (mechanical shearing/homogenisation and recovery of intercellular fluids -IFs-) were evaluated and compared in terms of purified antibody yields, antibody degradation and total phenolic compounds content. Mechanical grinding from fresh leaf tissues gave the highest purification yield (75 mg/kg Fresh Weight -75% intact tetrameric IgG-) and total phenolics concentration in the range of 420 μg/g FW. The second extraction procedure, based on the recovery of IFs, gave purification yields of 15-20 mg/kg FW (corresponding to 27% of total soluble protein) in which about 40% of purified protein is constituted by fully assembled IgG with a total phenolic compounds content reduced by one order of magnitude (21 μg/g FW). Despite a higher antibody degradation, purification from intercellular fluids demonstrated to be very promising since extraction procedures resulted extremely fast and amenable to scaling-up. Overall data highlight that different extraction procedures can dramatically affect the proteolytic degradation and quality of antibody purified from agroinfiltrated N. benthamiana leaves. Based on these results, we optimised a pilot-scale purification protocol using a two-step purification procedure from batches of fresh agroinfiltrated leaves (250 g) allowing purification of milligram quantities (average yield 40 mg/kg FW) of fully assembled and functional IgG with a 99.4% purity, free of phenolic and alkaloid compounds with low endotoxin levels (<1 EU/ml).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20229286     DOI: 10.1007/s11248-010-9382-9

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  29 in total

1.  Transient co-expression for fast and high-yield production of antibodies with human-like N-glycans in plants.

Authors:  Louis-P Vézina; Loïc Faye; Patrice Lerouge; Marc-André D'Aoust; Estelle Marquet-Blouin; Carole Burel; Pierre-Olivier Lavoie; Muriel Bardor; Véronique Gomord
Journal:  Plant Biotechnol J       Date:  2009-06       Impact factor: 9.803

2.  Different subcellular localization and glycosylation for a functional antibody expressed in Nicotiana tabacum plants and suspension cells.

Authors:  Benoit De Muynck; Catherine Navarre; Yannick Nizet; Johannes Stadlmann; Marc Boutry
Journal:  Transgenic Res       Date:  2009-01-14       Impact factor: 2.788

3.  Development of an aqueous two-phase partitioning system for fractionating therapeutic proteins from tobacco extract.

Authors:  Dimitris Platis; Nikolaos E Labrou
Journal:  J Chromatogr A       Date:  2006-07-10       Impact factor: 4.759

4.  Affinity-purification of a TMV-specific recombinant full-size antibody from a transgenic tobacco suspension culture.

Authors:  R Fischer; Y C Liao; J Drossard
Journal:  J Immunol Methods       Date:  1999-06-24       Impact factor: 2.303

5.  Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure.

Authors:  Richard Strasser; Johannes Stadlmann; Matthias Schähs; Gabriela Stiegler; Heribert Quendler; Lukas Mach; Josef Glössl; Koen Weterings; Martin Pabst; Herta Steinkellner
Journal:  Plant Biotechnol J       Date:  2008-03-13       Impact factor: 9.803

6.  Expression of different tenascin isoforms in normal, hyperplastic and neoplastic human breast tissues.

Authors:  L Borsi; B Carnemolla; G Nicolò; B Spina; G Tanara; L Zardi
Journal:  Int J Cancer       Date:  1992-11-11       Impact factor: 7.396

7.  Improved virus neutralization by plant-produced anti-HIV antibodies with a homogeneous beta1,4-galactosylated N-glycan profile.

Authors:  Richard Strasser; Alexandra Castilho; Johannes Stadlmann; Renate Kunert; Heribert Quendler; Pia Gattinger; Jakub Jez; Thomas Rademacher; Friedrich Altmann; Lukas Mach; Herta Steinkellner
Journal:  J Biol Chem       Date:  2009-05-28       Impact factor: 5.157

8.  Application of a PEG/salt aqueous two-phase partition system for the recovery of monoclonal antibodies from unclarified transgenic tobacco extract.

Authors:  Dimitris Platis; Nikolaos E Labrou
Journal:  Biotechnol J       Date:  2009-09       Impact factor: 4.677

9.  Expression, intracellular targeting and purification of HIV Nef variants in tobacco cells.

Authors:  Carla Marusic; James Nuttall; Giampaolo Buriani; Chiara Lico; Raffaele Lombardi; Selene Baschieri; Eugenio Benvenuto; Lorenzo Frigerio
Journal:  BMC Biotechnol       Date:  2007-02-26       Impact factor: 2.563

Review 10.  Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants.

Authors:  H Daniell; S J Streatfield; K Wycoff
Journal:  Trends Plant Sci       Date:  2001-05       Impact factor: 18.313

View more
  6 in total

1.  Production of different glycosylation variants of the tumour-targeting mAb H10 in Nicotiana benthamiana: influence on expression yield and antibody degradation.

Authors:  Raffaele Lombardi; Marcello Donini; Maria Elena Villani; Patrizia Brunetti; Kazuhito Fujiyama; Hiroyuki Kajiura; Matthew Paul; Julian K-C Ma; Eugenio Benvenuto
Journal:  Transgenic Res       Date:  2012-01-12       Impact factor: 2.788

2.  Functional characterization of the recombinant HIV-neutralizing monoclonal antibody 2F5 produced in maize seeds.

Authors:  M Sabalza; L Madeira; C van Dolleweerd; J K Ma; T Capell; P Christou
Journal:  Plant Mol Biol       Date:  2012-09-11       Impact factor: 4.076

3.  An Accessory Protease Inhibitor to Increase the Yield and Quality of a Tumour-Targeting mAb in Nicotiana benthamiana Leaves.

Authors:  Philippe V Jutras; Carla Marusic; Chiara Lonoce; Carole Deflers; Marie-Claire Goulet; Eugenio Benvenuto; Dominique Michaud; Marcello Donini
Journal:  PLoS One       Date:  2016-11-28       Impact factor: 3.240

4.  Production of two SARS-CoV-2 neutralizing antibodies with different potencies in Nicotiana benthamiana.

Authors:  Rachele Frigerio; Carla Marusic; Maria Elena Villani; Chiara Lico; Cristina Capodicasa; Emanuele Andreano; Ida Paciello; Rino Rappuoli; Anna Maria Salzano; Andrea Scaloni; Selene Baschieri; Marcello Donini
Journal:  Front Plant Sci       Date:  2022-09-05       Impact factor: 6.627

5.  Protection of recombinant mammalian antibodies from development-dependent proteolysis in leaves of Nicotiana benthamiana.

Authors:  Stéphanie Robert; Moustafa Khalf; Marie-Claire Goulet; Marc-André D'Aoust; Frank Sainsbury; Dominique Michaud
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

6.  The human anti-HIV antibodies 2F5, 2G12, and PG9 differ in their susceptibility to proteolytic degradation: down-regulation of endogenous serine and cysteine proteinase activities could improve antibody production in plant-based expression platforms.

Authors:  Melanie Niemer; Ulrich Mehofer; Juan Antonio Torres Acosta; Maria Verdianz; Theresa Henkel; Andreas Loos; Richard Strasser; Daniel Maresch; Thomas Rademacher; Herta Steinkellner; Lukas Mach
Journal:  Biotechnol J       Date:  2014-04       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.